Consensus conference definitions for sepsis, septic shock, acute lung injury, and acute respiratory distress syndrome: Time for a reevaluation

被引:249
作者
Abraham, E
Matthay, MA
Dinarello, CA
Vincent, JL
Cohen, J
Opal, SM
Glauser, M
Parsons, P
Fisher, CJ
Repine, JE
机构
[1] Univ Colorado, Hlth Sci Ctr, Div Pulm Sci Crit Care Med, Denver, CO 80262 USA
[2] Univ Colorado, Hlth Sci Ctr, Div Infect Dis, Denver, CO USA
[3] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA
[4] Free Univ Brussels, Erasme Hosp, Dept Intens Care, B-1050 Brussels, Belgium
[5] Hammersmith Hosp, Dept Infect Dis, London, England
[6] Brown Univ, Sch Med, Div Infect Dis, Providence, RI 02912 USA
[7] CHU Vaudois, Div Malad Infect, CH-1011 Lausanne, Switzerland
[8] Cleveland Clin Fdn, Dept Pulm, Cleveland, OH 44195 USA
[9] Cleveland Clin Fdn, Dept Crit Care Med, Cleveland, OH 44195 USA
关键词
sepsis; acute respiratory distress syndrome (ARDS); acute lung injury; septic shock; cytokines; consensus conference; definitions; tumor necrosis factor-alpha; endotoxin; infection; organ dysfunction;
D O I
10.1097/00003246-200001000-00039
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Definitions for sepsis, septic shock, acute lung injury (ALI), and acute respiratory distress syndrome (ARDS) were developed by consensus conferences with the goal of achieving standardization of terminology and improved homogeneity of patient populations in clinical studies. Although such definitions have been useful in epidemiologic investigations, the criteria specified by the consensus conferences are broad and insufficiently specific to address the problem of heterogeneous mechanisms leading to clinical syndromes, An important challenge is to progress from clinical syndromes, as presently defined, to more specific entities that are delineated by alterations in specific immunologic or biochemical pathways. Such mechanistic definitions will provide more homogeneous groups of patients who can be identified at early stages of their clinical course. This approach encourages focused investigation of pathways leading to organ system dysfunction and death and, also, provides an efficient framework for the development of new therapies useful in critically ill patients.
引用
收藏
页码:232 / 235
页数:4
相关论文
共 29 条
  • [1] Abraham E, 1998, LANCET, V351, P929
  • [2] Abraham E, 1997, WESTERN J MED, V166, P195
  • [3] p55 tumor necrosis factor receptor fusion protein in the treatment of patients with severe sepsis and septic shock - A randomized controlled multicenter trial
    Abraham, E
    Glauser, MP
    Butler, T
    Garbino, J
    Gelmont, D
    Laterre, PF
    Kudsk, K
    Bruining, HA
    Otto, C
    Tobin, E
    Zwingelstein, C
    Lesslauer, W
    Leighton, A
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (19): : 1531 - 1538
  • [4] Berkova N, 1996, BIOTECHNOL APPL BIOC, V23, P163
  • [5] The effects of ibuprofen on the physiology and survival of patients with sepsis
    Bernard, GR
    Wheeler, AP
    Russell, JA
    Schein, R
    Summer, WR
    Steinberg, KP
    Fulkerson, WJ
    Wright, PE
    Christman, BW
    Dupont, WD
    Higgins, SB
    Swindell, BB
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (13) : 912 - 918
  • [6] THE AMERICAN-EUROPEAN CONSENSUS CONFERENCE ON ARDS - DEFINITIONS, MECHANISMS, RELEVANT OUTCOMES, AND CLINICAL-TRIAL COORDINATION
    BERNARD, GR
    ARTIGAS, A
    BRIGHAM, KL
    CARLET, J
    FALKE, K
    HUDSON, L
    LAMY, M
    LEGALL, JR
    MORRIS, A
    SPRAGG, R
    COCHIN, B
    LANKEN, PN
    LEEPER, KV
    MARINI, J
    MURRAY, JF
    OPPENHEIMER, L
    PESENTI, A
    REID, L
    RINALDO, J
    VILLAR, J
    VANASBECK, BS
    DHAINAUT, JF
    MANCEBO, J
    MATTHAY, M
    MEYRICK, B
    PAYEN, D
    PERRET, C
    FOWLER, AA
    SCHALLER, MD
    HUDSON, LD
    HYERS, T
    KNAUS, W
    MATTHAY, R
    PINSKY, M
    BONE, RC
    BOSKEN, C
    JOHANSON, WG
    LEWANDOWSKI, K
    REPINE, J
    RODRIGUEZROISIN, R
    ROUSSOS, C
    ANTONELLI, MA
    BELOUCIF, S
    BIHARI, D
    BURCHARDI, H
    LEMAIRE, F
    MONTRAVERS, P
    PETTY, TL
    ROBOTHAM, J
    ZAPOL, W
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1994, 149 (03) : 818 - 824
  • [7] Sepsis: A new hypothesis for pathogenesis of the disease process
    Bone, RC
    Grodzin, CJ
    Balk, RA
    [J]. CHEST, 1997, 112 (01) : 235 - 243
  • [8] DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS
    BONE, RC
    BALK, RA
    CERRA, FB
    DELLINGER, RP
    FEIN, AM
    KNAUS, WA
    SCHEIN, RMH
    SIBBALD, WJ
    [J]. CHEST, 1992, 101 (06) : 1644 - 1655
  • [9] Early detection of type III procollagen peptide in acute lung injury - Pathogenetic and prognostic significance
    Chesnutt, AN
    Matthay, MA
    Tibayan, FA
    Clark, JG
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1997, 156 (03) : 840 - 845
  • [10] Connelly KG, 1997, ANNU REV MED, V48, P429